@inproceedings{inproceedings, title  = {{Cost-effectiveness of bosentan versus epoprostenol and no active treatment when added to palliative care for UK patients with pulmonary arterial hypertension of WHO functional class III}},

 url = {{}},

 year = {{2008}},

 month = {{9}},

 author = {{Stevenson MD and Macdonald FC and Langley J and Akehurst RL}},

 volume = {{29}},

 journal = {{EUROPEAN HEART JOURNAL}},

 pages = {{859-859}},

 note = {{Accessed on 2025/02/05}}}